Andrew L Feldman
Overview
Explore the profile of Andrew L Feldman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
209
Citations
6390
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wenzl K, Stokes M, Novak J, Bock A, Khan S, Hopper M, et al.
Blood Cancer J
. 2024 Jun;
14(1):100.
PMID: 38902256
Recent genetic and molecular classification of DLBCL has advanced our knowledge of disease biology, yet were not designed to predict early events and guide anticipatory selection of novel therapies. To...
12.
Hilton L, Collinge B, Ben-Neriah S, Alduaij W, Shaalan H, Weng A, et al.
Blood
. 2024 May;
144(5):525-540.
PMID: 38701426
Rearrangements that place the oncogenes MYC, BCL2, or BCL6 adjacent to superenhancers are common in mature B-cell lymphomas. Lymphomas with diffuse large B-cell lymphoma (DLBCL) or high-grade morphology with both...
13.
Arcaini L, Bommier C, Alderuccio J, Merli M, Fabbri N, Nizzoli M, et al.
EClinicalMedicine
. 2024 Apr;
72:102592.
PMID: 38633575
Background: Marginal zone lymphomas (MZL), comprised of three unique but related subtypes, lack a unifying prognostic score applicable to all the patients in need for systemic chemotherapy and/or immunotherapy. Methods:...
14.
Mark E, Kempf W, Guitart J, Pulitzer M, Mitteldorf C, Hristov A, et al.
Am J Surg Pathol
. 2024 Mar;
48(5):501-510.
PMID: 38533681
Lymphomatoid papulosis (LyP) has several histopathologic presentations. LyP featuring gamma-delta (γδ) T-cell receptor expression may masquerade as and may be misdiagnosed as aggressive cutaneous T-cell lymphoma, particularly primary cutaneous γδ...
15.
16.
Clemens M, Myckatyn T, Di Napoli A, Feldman A, Jaffe E, Haymaker C, et al.
Plast Reconstr Surg
. 2024 Feb;
154(3):473-483.
PMID: 38412359
Background: In the absence of high-quality evidence, there is a need for guidelines and multidisciplinary consensus recommendations on breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL). The purpose of this expert consensus...
17.
Tavolara T, Khan Niazi M, Feldman A, Jaye D, Flowers C, Cooper L, et al.
Diagn Pathol
. 2024 Jan;
19(1):17.
PMID: 38243330
Background: c-MYC and BCL2 positivity are important prognostic factors for diffuse large B-cell lymphoma. However, manual quantification is subject to significant intra- and inter-observer variability. We developed an automated method...
18.
Cerhan J, Maurer M, Link B, Feldman A, Habermann T, Jaye D, et al.
Am J Hematol
. 2024 Jan;
99(3):408-421.
PMID: 38217361
To address the current and long-term unmet health needs of the growing population of non-Hodgkin lymphoma (NHL) patients, we established the Lymphoma Epidemiology of Outcomes (LEO) cohort study (NCT02736357; https://leocohort.org/)....
19.
Laoruangroj C, Atherton P, Wiseman G, Ansell S, Feldman A, Schumacher P, et al.
Leuk Lymphoma
. 2024 Jan;
65(3):333-338.
PMID: 38189774
Patients with asymptomatic follicular lymphoma (AFL) are candidates for observation or immunotherapy. Given the effectiveness of radiation therapy in FL, another option is 90Yttrium-ibritumomab tiuxetan radioimmunotherapy (RIT). We conducted a...
20.
Le M, Oishi N, Satou A, Miyaoka M, Kawashima I, Mochizuki K, et al.
Hum Pathol
. 2023 Nov;
143:10-16.
PMID: 38000677
Extranodal NK/T-cell lymphoma (ENKTL) generally expresses cytotoxic molecules, including granzyme B (GZMB), T-cell-restricted intracellular antigen-1 (TIA-1), and perforin; however, the expression of these molecules varies across cases. We performed gene...